logo

LYRA

Lyra Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
3.92 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is LYRA a Good Buy Right Now?
  • Based on a composite score of 3.92/10, we rate LYRA as a Netural. Our analysis breaks down into 3.04/10 for Fundamentals, 3.99/10 for Technicals, and 4.33/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is LYRA undervalued or overvalued?
Technical Analysis of LYRA?
What is the analyst consensus for LYRA?